Followers | 416 |
Posts | 34739 |
Boards Moderated | 1 |
Alias Born | 08/22/2004 |
Tuesday, October 12, 2021 9:17:38 AM
The goal of the Diocheck patch is to monitor the critical gap between when a person receives a COVID-19 vaccine and when a protective level of antibodies is circulating in the body, which current reports suggest could take several weeks. It could also signal when the antibodies stimulated by a vaccine have declined and the person needs a booster.
‘This exclusive contract with Diomics to manufacture Diocheck™ allows Nutriband and our contract manufacturing subsidiary, Pocono Pharma, to showcase our capabilities with innovative new patch technologies," said Gareth Sheridan, CEO of Nutriband.
Based on Diomics' proprietary usage of an FDA-approved material, Diomat™ bioresorbable polymer, Diocheck detects and reports within 24 to 36 hours whether a person has developed a circulating level of COVID-19 specific antibodies. A positive response causes a change in skin color that is visible through the Diocheck skin patch, which resembles a nicotine patch and is expected to be effective for up to 14 days. Diomics has applied to the FDA for approval of the Diocheck™ device.
The Diocheck™ Transdermal Test is intended to be used only as an aid in monitoring SARS-CoV-2 infections or vaccine efficacy. The user places the patch on the inside of either forearm for 24 hours, and then removes the patch and monitors that area of the skin for the next 24-36 hours. If the user has not been vaccinated and has a positive response in the form of a small induration and/or erythema on the skin, they are directed to contact a medical professional for additional testing to confirm a potential SARS-CoV-2 infection. If the user has been vaccinated and does not have a positive response in the form of a small induration and/or erythema on the skin, the user is directed to contact a medical professional for additional testing to confirm efficacy of their vaccine.
Recent NTRB News
- IBN Coverage Initiated for Nutriband Inc. • GlobeNewswire Inc. • 04/25/2024 11:00:00 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 08:57:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:40:43 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 01/23/2024 03:53:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 10:07:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 10:25:23 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 07/19/2023 07:53:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/14/2023 01:15:31 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 07/14/2023 01:00:02 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/06/2023 01:56:04 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM